Wellgistics Health Confirms Nasdaq Delisting Threat for Negative Equity, October Deadline Set
Summary
Wellgistics Health disclosed it received a Nasdaq notice on April 13, 2026, for failing the minimum stockholders' equity rule (5550(b)(1)) due to $(12.4) million in negative equity as of December 31, 2025. This specific delisting threat follows the company's May 19 10-Q, which already highlighted multiple Nasdaq delisting warnings and a going concern. Nasdaq has granted an extension until October 12, 2026, but failure to demonstrate compliance by then could result in delisting for the micro-cap company.
At the time of this announcement, WGRX was trading at $3.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.3M. The 52-week trading range was $3.04 to $97.50. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.